Financial Data and Key Metrics Changes - For the full year 2025, total revenues reached $1.64 billion, representing a growth of 28% compared to the previous year, and more than doubling since the end of 2022 [6][23] - Adjusted EBITDA for 2025 grew by 31% to $303 million, outpacing revenue growth [7][23] - System same-shop sales growth was 5.6% for the year, with Q4 showing a growth of 7.7% [6][24] - Company-operated contribution margin was approximately 29% for 2025, reflecting over 400 basis points of margin expansion since 2022 [7][23] Business Line Data and Key Metrics Changes - New shop growth contributed significantly, with 154 new shop openings in 2025, leading to a total of 1,136 system-wide shops [6][24] - Company-operated same-shop sales growth in Q4 was 9.7%, driven by strong transaction growth of 7.6% [27] - System-wide average unit volumes (AUVs) reached a record $2.1 million, indicating strong shop-level economics [8][23] Market Data and Key Metrics Changes - The company expanded into seven contiguous states, including North Carolina, increasing its market presence to 25 states [11] - The new food program has been rolled out to over 300 shops across 11 states, with plans for completion by the end of 2026 [19] Company Strategy and Development Direction - The company aims to reach 2,029 shops by 2029, with a clear strategy focused on growth through people and brand investment [9][19] - A shift towards a foundational top-of-the-funnel paid advertising engine has been implemented to enhance brand awareness [14] - The company is also focusing on expanding its CPG platform, which includes creamers and ready-to-drink offerings, to drive long-term growth [15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate competitive pressures and maintain traffic strength, citing strong same-shop sales performance [38] - The company anticipates continued transaction growth in 2026, with expectations of opening at least 181 new system shops [12][27] - Management acknowledged commodity cost pressures but remains optimistic about achieving long-term contribution margin goals [24][29] Other Important Information - The company has built a strong pipeline of regional operator candidates, increasing from approximately 400 to 475 since the end of 2022 [10] - The loyalty program, Dutch Rewards, surpassed 15 million members, with 72% of system transactions attributed to it [16] Q&A Session Summary Question: How will the company protect traffic during competitive pressures? - Management highlighted the strength of their value proposition and service quality, expressing confidence in maintaining traffic strength despite competition [38] Question: What is the mandate for the new Chief Shops Officer? - The focus will be on supporting baristas and enhancing operational initiatives, including the food program and mobile ordering [40] Question: What metrics can be shared regarding the food program's impact? - Management is tracking various operational metrics and is pleased with the initial results, indicating a long-term strategy for food offerings [46] Question: How does the company view the Clutch acquisition? - The acquisition is seen as a capital-efficient way to expand into new markets, with plans for conversion and opening in Q2 and Q3 [60][84] Question: What is the outlook for competition in specific markets? - Management noted that they are not currently seeing pressures on site availability or costs due to competition, maintaining a strong position in real estate [71]

Atomera (NasdaqCM:ATOM) Q4 2025 Earnings call February 12, 2026 05:00 PM ET Company ParticipantsFrank Laurencio - CFOMike Bishop - Investor RelationsScott Bibaud - CEOConference Call ParticipantsRichard Shannon - AnalystMike BishopHello everyone, and welcome to Atomera's fourth quarter and fiscal year 2025 update call. I'd like to remind everyone that this call and webinar are being recorded, and a replay will be available on Atomera's IR website for one year. I'm Mike Bishop with the company's investor rel ...

Financial Data and Key Metrics Changes - Total revenue for 2025 was reported at $673 million, representing a 20% growth over 2024 and exceeding the upper end of guidance [11] - Net loss for the year was $575 million, or $5.83 per share [12] - Cash, cash equivalents, and marketable securities as of December 31 were $738 million [12] - Guidance for 2026 total revenue is expected to be between $730 million and $760 million, reflecting an 8%-13% growth over 2025 [12][13] Business Line Data and Key Metrics Changes - Crysvita contributed $481 million in revenue, with a 17% growth over 2024 [11] - Dojolvi generated $96 million, representing a 9% growth over 2024 [11] - Evkeeza saw significant growth, contributing $59 million, which is an 84% increase over 2024 [11] - Mepsevii contributed $37 million, continuing to treat patients in an ultra-rare indication [11] Market Data and Key Metrics Changes - The commercial business delivered a significant 20% year-over-year growth in 2025, with treatments reaching over 35 countries [8] - In Latin America, Crysvita's business is anchored in Brazil and Argentina, with solid reimbursement growth in Mexico and Colombia [16][17] - Dojolvi has seen continuous growth in EMEA, with regulatory wins in Kuwait and the U.K. [18] Company Strategy and Development Direction - The company aims for profitability by 2027, implementing a strategic restructuring plan to reduce operating expenses and align resources with high-impact opportunities [9][10] - The plan includes a 10% workforce reduction, impacting approximately 130 employees [10] - The company is focused on launching three additional treatments over the next two years while continuing to grow its base business of four commercial products [10][24] Management's Comments on Operating Environment and Future Outlook - Management highlighted 2026 as a significant year with potential approvals in MPS IIIA and glycogen storage disease type Ia, along with pivotal data readout in Angelman syndrome [4] - The management expressed confidence in the ability to deliver the next phase of growth required to reach profitability [20] - The company is addressing the FDA's incomplete response letter regarding UX111 and is working on resubmitting the BLA with additional documentation [7][21] Other Important Information - The company has a strong commercial infrastructure and experienced team to execute complex rare disease therapies globally [20] - The strategic restructuring is expected to enable the company to diversify its pipeline beyond gene therapy [54] Q&A Session Summary Question: What was the decision behind using cognition as the primary endpoint for the Angelman study? - The decision was based on the belief that cognition is fundamental and intertwined with communication, which takes more time to develop [27] Question: Can you provide insights on the patient baseline profile for the Angelman study? - The baseline data from the phase II trial is reflective of the phase III program, and the company is comfortable with the comparability [33] Question: How does the company plan to achieve profitability in 2027? - The pathway to profitability includes continued growth from current products and a reduction in combined R&D and SG&A expenses [40][42] Question: What is the timeline for the resubmission of the BLA in response to the IRL? - The resubmission is expected to take a couple of weeks for the FDA to determine if all required documents are included, with a PDUFA date set approximately six months after resubmission [72] Question: What is the expected launch trajectory for GSDIa? - The market for GSDIa is expected to develop steadily, with strong demand anticipated, but not as urgent as MPS IIIA [76]

Financial Data and Key Metrics Changes - For the full year 2025, revenue grew 12% to approximately $1.47 billion, gross profit increased 30% to approximately $426 million, and adjusted EBITDA grew more than 80% to over $100 million [4][14] - In Q4 2025, revenue increased 6% year-over-year to approximately $437 million, gross profit increased more than 30% year-over-year, and adjusted EBITDA increased more than 60% year-over-year [14][15] Business Line Data and Key Metrics Changes - Gaming components and systems delivered strong double-digit growth for both the fourth quarter and the full year, driven by strength in memory and core components [15] - Gamer and Creator Peripherals delivered single-digit full-year growth, led by continued momentum in sim racing and creator products, while lower demand in North America resulted in a low single-digit revenue decline in Q4 [15] Market Data and Key Metrics Changes - Softer holiday demand was observed in North America for gaming peripherals, but stronger international performance was noted [6] - The company expects demand to improve in 2026, particularly with the anticipated launch of GTA 6 in Q4 [6] Company Strategy and Development Direction - The company aims to improve the quality of growth through integrated platforms and innovation, focusing on higher margin gaming, sim racing, and creator categories [10] - Corsair plans to scale its direct-to-consumer business, which accounted for nearly 20% of revenue in 2025, with double-digit growth in web traffic and social engagement [11] - The opening of the first Corsair retail store is part of a strategy to deepen consumer engagement and grow brand awareness [9] Management's Comments on Operating Environment and Future Outlook - Management acknowledges a conservative outlook for the Gaming Components and Systems segment due to semiconductor shortages, while expecting double-digit growth in the Gamer and Creator Peripherals segment [18] - The company has a strong position in the memory business and aims to continue acquiring inventory to support demand [33] Other Important Information - Corsair announced its first share repurchase authorization of up to $50 million, reflecting confidence in the attractiveness of its shares [16] - The company is focused on margin expansion through operational discipline and smart inventory management [10][15] Q&A Session Summary Question: Guidance and Market Visibility - The company has embedded conservatism in its guidance due to market conditions, particularly in the semiconductor space [23][24] Question: Components Margins - Components margins improved due to higher memory product prices and growth in sim racing, with expectations for sustainability [25][26] Question: Memory Revenue - Memory revenue grew 24% year-over-year to $156 million, with a gross margin of 35% [32] Question: Semiconductor Situation - The company has visibility into the semiconductor market and expects tight conditions to persist for the next couple of years, but has strategies to manage inventory [50][51] Question: Elgato Recurring Revenue - The company is working on a recurring revenue model for Elgato, with over 2 million active users on the marketplace [60][61]

Financial Data and Key Metrics Changes - The company reported a Gross Transaction Value (GTV) of $9.85 billion for Q4 2025, representing a 14% year-over-year increase, marking the strongest growth in three years [21] - Orders reached 89.5 million, up 16% year-over-year, while the average order value decreased by 1% year-over-year [21] - GAAP net income was $81 million, down 46% year-over-year, primarily due to higher G&A expenses related to non-recurring legal matters [23] - Adjusted EBITDA grew 20% year-over-year to $303 million, with operating cash flow of $184 million, also up 20% year-over-year [23] Business Line Data and Key Metrics Changes - Advertising and other revenue grew 10% year-over-year, driven by strong GTV performance and an increase in active brand partners to over 9,000 [22] - Transaction revenue grew 13% year-over-year, representing 7.1% of GTV, which remained flat year-over-year [21] - The enterprise platform powered more than 380 grocery e-commerce sites, with significant growth opportunities identified [9] Market Data and Key Metrics Changes - The company noted that grocery remains a massive and fragmented market, still early in its online journey, which presents significant growth opportunities [7] - The company has expanded its reach to more than 2,200 retail banners across nearly 100,000 locations [8] Company Strategy and Development Direction - The company's strategy focuses on being the trusted platform for grocery needs, providing technology for grocers, and being the preferred advertising ecosystem for brands [8] - The company is leveraging generative AI to enhance execution across its platform, driving efficiency and compounding advantages [8][14] - The company aims to accelerate its growth and capitalize on the omnichannel transformation of grocery [19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to drive durable, profitable growth, citing strong momentum and a positive outlook for Q1 2026 [6][24] - The company anticipates GTV for Q1 2026 to range between $10.125 billion and $10.275 billion, representing year-over-year growth of 11%-13% [25] - Management acknowledged the competitive landscape but emphasized the company's strong market position and differentiation [39] Other Important Information - The company will transition to an annual shareholder letter starting Q1 2026, aiming for a more holistic assessment of its long-term strategy [3] - The company repurchased $1.4 billion of shares in 2025, including $1.1 billion in Q4 alone [24] Q&A Session Summary Question: How should we think about the scope of the opportunity in marketplace and enterprise adoption? - Management highlighted that both marketplace and enterprise segments are growing, with enterprise providing deeper strategic conversations and technical integrations with retailers [30] Question: What has driven the acceleration in business metrics? - Management noted strong user growth and engagement, with 26 million customers using the platform in 2025 and record retention rates [36] Question: Can you discuss the stronger-than-expected advertising performance? - Management attributed the strong advertising performance to GTV growth and a diversification strategy that has expanded the advertising ecosystem [46] Question: How are you approaching international growth? - Management expressed optimism about international markets, noting that many retailers are still underdeveloped in e-commerce, presenting a significant opportunity [50] Question: What is the strategy regarding price parity initiatives? - Management indicated that retailers adopting price parity tend to outperform those with markups, and they are actively discussing pricing strategies with partners [60] Question: What updates can you provide on Instacart+ adoption? - Management reported that Instacart+ continues to represent the majority of GTV and orders, with paid members showing higher engagement and retention [67]

VistaGen Therapeutics (NasdaqCM:VTGN) Q3 2026 Earnings call February 12, 2026 05:00 PM ET Company ParticipantsElemer Piros - Managing DirectorJoshua Prince - COOMark McPartland - Senior Vice President, Investor RelationsNick Tressler - CFOShawn K. Singh - President and CEOConference Call ParticipantsAndrew Fein - Managing Director and Senior Biotechnology AnalystNone - AnalystNone - AnalystOperatorGood day, everyone. Thank you for standing by. Welcome to the Vistagen Therapeutics Fiscal Year 2026, third qua ...

Financial Data and Key Metrics Changes - Revenue in Q1 of fiscal 2026 increased more than four times to $21.4 million compared to $4.6 million in Q1 of fiscal 2025 [16] - Gross margin increased significantly to 78.6% in Q1 of fiscal 2026 from 24.5% in Q1 of fiscal 2025, primarily driven by staking revenue from the Solana treasury strategy [16] - Net loss for Q1 of fiscal 2026 was approximately $585.6 million, compared to a net loss of $0.7 million in Q1 of fiscal 2025, largely due to a decline in the fair value of SOL holdings [18] Business Line Data and Key Metrics Changes - Forward held approximately 6,962,501 Solana as of December 31, 2025, with over 99% staked, generating a staking yield between 6.5% and 7.2% [13] - Fully diluted SOL per share increased from 0.0604 at the end of September 2025 to 0.0624 as of December 31, 2025, representing a growth of roughly 13% in the fiscal first quarter [14] Market Data and Key Metrics Changes - Solana continues to lead in decentralized exchange trading volumes, active users, and developer engagement, demonstrating resilience and performance [6][7] - Institutional engagement has expanded significantly, with major financial institutions integrating Solana into their operations, such as WisdomTree launching regulated tokenized funds on Solana [7] Company Strategy and Development Direction - The company aims to build a permanent capital vehicle that participates directly in the growth of the Solana ecosystem, evolving beyond a treasury into an active value-generating business [5] - Forward Industries is focused on compounding SOL per share by engaging directly in economic activities on-chain rather than relying solely on passive exposure [6] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the volatility in the market but emphasizes that Solana is now being evaluated based on actual performance rather than theoretical scalability [6] - The company believes that the opportunity in front of Solana is increasingly clear, with significant growth in stablecoins, payments, and DeFi applications [7] Other Important Information - Forward became one of the first public companies to have its SEC-registered shares live on a public blockchain, allowing eligible non-US holders to use tokenized shares as collateral in DeFi [8][9] - The company launched fwdSOL, a proprietary liquid staking token, representing approximately 25% of its SOL holdings, allowing for efficient deployment of staked SOL [9][10] Q&A Session Summary Question: How has the company navigated recent token price volatility? - Management noted that SOL is down approximately 70% from its all-time high, which is typical in the crypto market, and emphasized maintaining a clean balance sheet to avoid risks faced by competitors [19][20] Question: What is the company's approach to potential M&A? - The company is looking for accretive acquisitions and is well-positioned to capitalize on opportunities due to its lack of institutional debt, allowing it to play offense in a dislocated market [23][24] Question: How should shareholders view SOL per share as a performance metric? - Management indicated that SOL per share growth is a key performance indicator, with a target to consistently generate returns greater than the staking yield [24] Question: What factors influence capital allocation decisions? - The company evaluates capital allocation based on market conditions, trading premiums or discounts, and the relative value of potential M&A opportunities [38][39] Question: How do staking yields trend with network usage? - Management clarified that increased validator participation does not impact yields for stakers, and as network activity grows, yields are expected to increase due to higher transaction fees [43][44]

Procore Technologies (NYSE:PCOR) Q4 2025 Earnings call February 12, 2026 05:00 PM ET Company ParticipantsAdam Borg - Managing Director - Equity ResearchAjei Gopal - President and CEOAlexandra Geller - Head of Investor RelationsDavid Hynes - Managing Director, Equity Research - Enterprise SoftwareHoward Fu - CFOKen Wong - Managing Director - Software ResearchMatthew Martino - VP, Equity Research - SoftwareSaket Kalia - Managing Director - Security, Design, and Vertical SoftwareConference Call ParticipantsDyl ...

Bio-Rad Laboratories (NYSE:BIO) Q4 2025 Earnings call February 12, 2026 05:00 PM ET Company ParticipantsEdward Chung - VP of Investor RelationsJon DiVincenzo - President and COONorman Schwartz - CEORoop Lakkaraju - EVP and CFOConference Call ParticipantsDan Leonard - Managing Director and Senior Equity Research AnalystJack Meehan - Partner and Senior Equity Research AnalystTycho Peterson - Managing Director and Senior Equity Research AnalystOperatorGood day, everyone, and welcome to the Bio-Rad fourth quart ...

Fortune Brands Innovations (NYSE:FBIN) Q4 2025 Earnings call February 12, 2026 05:00 PM ET Company ParticipantsCurt Worthington - VP of Finance and Investor RelationsJon Baksht - CFONick Fink - CEOPhil Ng - Managing DirectorStephen Kim - Senior Managing Director and Head of the Housing Research TeamSusan Kilsby - Non-Executive Chair of the BoardConference Call ParticipantsJohn Lovallo - Managing Director and Senior Equity AnalystMatthew Bouley - Director and Senior Equity Research AnalystMichael Rehaut - Ma ...